Skip to main content

$0.050 (0%)

High

$0.05

Low

$0.05

Trades

132

Turnover

$407,237

Volume

8,117,500
30 June 2023 at 3:59pm
Register to track ALA and receive email alerts.
Subject
ALA Ann: Update - Proposed issue of securities - ALA

ALA Ann: Share Purchase Plan (SPP) Closing Date Extended

ALA Ann: ALA advances iNKT technology option with UNC - supplement

ALA Ann: Notification regarding unquoted securities - ALA

ALA Ann: ALA advances iNKT technology option with UNC

ALA Ann: Investor Webinar Presentation

ALA Ann: Becoming a substantial holder RM

ALA Ann: Investor Webinar

ALA Ann: Share Purchase Plan (SPP) Offer Booklet

ALA Ann: Notice Under Section 708A

ALA Ann: Application for quotation of securities - ALA

ALA Ann: Investor Presentation

ALA Ann: Proposed issue of securities - ALA

ALA Ann: Proposed issue of securities - ALA

ALA Ann: Proposed issue of securities - ALA

ALA Ann: AROVELLA COMPLETES $4M PLACEMENT & LAUNCHES $1M SPP

ALA Ann: Trading Halt

ALA Ann: ALA presents at the 5th annual Allogenic Cell Therapy Summit

ALA Ann: Change in substantial holding

ALA Ann: Change of Director's Interest Notice x3

ALA Ann: Notice Under Section 708A

ALA Ann: Application for quotation of securities - ALA

ALA Ann: Arovella's OroMist R&D facility closure completed

ALA Ann: Response to ASX Query

ALA Ann: Constitution

ALA Ann: Quarterly Appendix 4C and Activities Report

ALA Ann: Notice Under Section 708A

ALA Ann: Application for quotation of securities - ALA

ALA Ann: Results of General Meeting

ALA Ann: Chairman's address and CEO's presentation to EGM

ALA Ann: Response to ASX Aware Query

ALA Ann: Notification regarding unquoted securities - ALA

ALA Ann: Arovella AACR Poster Webinar Presentation

ALA Ann: ALA-101 confers survival benefit in leukemia model

ALA Ann: Response to ASX Price Query

ALA Ann: Change in substantial holding

ALA Ann: Explanatory Webinar Presentation

ALA Ann: Arovella iNKT Cell Platform Explanatory Webinar

ALA Ann: Notice of Extraordinary General Meeting/Proxy Form

ALA Ann: Arovella to present at NWR virtual healthcare conference

ALA Ann: Notice Under Section 708A

ALA Ann: Application for quotation of securities - ALA

ALA Ann: Proposed issue of securities - ALA

ALA Ann: Initial Director's Interest Notice

ALA Ann: Arovella appoints Dr Thomas Duthy as Non-Executive Chair

ALA Ann: Proposed issue of securities - ALA

ALA Ann: Notification regarding unquoted securities - ALA

ALA Ann: Notification of cessation of securities - ALA

ALA Ann: Arovella presents at Spark Plus Biotech Day in Singapore

ALA Ann: Appendix 4D and Half Year Report

Register to track ALA and receive email alerts.